author

Author: Don Obrien

Titan Company, Lupin, PNB Housing Finance in focus



Titan Company witnessed strong recovery in demand after the second wave across its consumer businesses with sales moving swiftly above or close to pre-pandemic levels in most of the divisions. Apart from its thrust on digital and omni channels, the company also accelerated its retail network expansion during the quarter.

Lupin announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) Brexpiprazole Tablets, to market a generic equivalent of Rexulti Tablets, of Otsuka Pharmaceutical Co., Ltd.





PNB Housing Finance announced that it has joined hands with CSC e‐Governance Services India, a strategic cornerstone of Digital India programme to provide last‐mile home loan facilities to individuals living in tier 2 and 3 cities.

Sobha said its new sales surged to 13.48 lakh square feet in Q2FY22 against 8.91 lakh square feet in Q2FY21. Total sales value increased to Rs 1030.2 crore from Rs 689.9 crore in the same period.

Nazara Technologies announced that its board has approved preferential allotment of fresh equity to raise Rs 315.30 crore from marquee institutional investors. The company will issue 1,429,266 equity shares of face value of Rs. 4/- each at a price of Rs. 2,206 per equity share.

Powered by Capital Market – Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor





Source link

Share:

Share on facebook
Facebook
Share on twitter
Twitter
Share on pinterest
Pinterest
Oliver Bolt

Oliver Bolt

On Key

Related Posts